Table 4.
SEERa | NCDB | |||||||
---|---|---|---|---|---|---|---|---|
5-year DSS rate [CI] | 5-year OS rate [CI] | 5-year OS rate [CI] | 10-year OS rate [CI] | |||||
Stage | 7th edition | 8th edition | 7th edition | 8th edition | 7th edition | 8th edition | 7th edition | 8th edition |
I | 99.8 [99.7–99.9] | 99.7 [99.6–99.8] | 98.1 [97.9–98.2] | 97.8 [97.7–98.0] | 96.9 [96.7–97.0] | 96.6 [96.5–96.7] | 91.5 [90.9–91.9] | 90.6 [90.1–91.0] |
II | 99.1 [98.7–99.4] | 96.7 [95.9–97.3] | 95.1 [94.2–95.8] | 90.7 [98.7–91.6] | 94.1 [93.6–94.5] | 88.0 [87.4–88.7] | 82.3 [80.0–84.3] | 70.9 [68.5–73.2] |
III | 98.8 [98.4–99.1] | 85.2 [81.7–87.9] | 94.9 [94.3–95.6] | 72.9 [68.9–76.4] | 92.7 [92.3–93.1] | 74.3 [72.2–76.2] | 79.9 [78.1–81.7] | 52.8 (48.9, 56.5) |
IV | 88.2 [86.9–89.3] | 66.9 [62.7–70.8] | 79.9 [78.4–81.3] | 55.3 [51.2–59.1] | 80.1 [79.2–81.1] | 49.5 [45.8–52.9] | 64.9 [62.7–67.2] | 23.3 [15.8–31.5] |
10-year DSS in SEER could not be calculated due to insufficient patient follow-up.
DSS, disease-specific survival; OS, overall survival; CI, confidence interval.